Xeris Biopharma Holdings (XERS) Current Leases (2022 - 2025)
Historic Current Leases for Xeris Biopharma Holdings (XERS) over the last 4 years, with Q3 2025 value amounting to $6.2 million.
- Xeris Biopharma Holdings' Current Leases rose 251.57% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 251.57%. This contributed to the annual value of $6.1 million for FY2024, which is 7396.28% up from last year.
- Xeris Biopharma Holdings' Current Leases amounted to $6.2 million in Q3 2025, which was up 251.57% from $6.2 million recorded in Q2 2025.
- In the past 5 years, Xeris Biopharma Holdings' Current Leases ranged from a high of $6.2 million in Q3 2025 and a low of $1.4 million during Q1 2023
- Over the past 4 years, Xeris Biopharma Holdings' median Current Leases value was $5.0 million (recorded in 2024), while the average stood at $4.3 million.
- As far as peak fluctuations go, Xeris Biopharma Holdings' Current Leases soared by 21933.7% in 2024, and later skyrocketed by 251.57% in 2025.
- Xeris Biopharma Holdings' Current Leases (Quarter) stood at $1.6 million in 2022, then skyrocketed by 121.2% to $3.5 million in 2023, then skyrocketed by 73.96% to $6.1 million in 2024, then grew by 1.88% to $6.2 million in 2025.
- Its Current Leases stands at $6.2 million for Q3 2025, versus $6.2 million for Q2 2025 and $6.1 million for Q1 2025.